Welcome to our dedicated page for Celanese Del news (Ticker: CE), a resource for investors and traders seeking the latest updates and insights on Celanese Del stock.
Celanese Corp Del (CE) delivers essential chemical solutions and specialty materials powering industries from automotive to electronics. This dedicated news hub provides investors and professionals with timely updates on corporate developments, financial milestones, and technical innovations.
Access authoritative coverage of earnings announcements, strategic partnerships, and product advancements that shape Celanese's market leadership. Our curated collection features official press releases and third-party analysis of critical initiatives in polymer engineering, cellulose derivatives, and sustainable production methods.
Key updates include financial performance reports, manufacturing capacity expansions, and R&D breakthroughs in high-performance materials. Track the company's progress in addressing evolving demands across global markets while maintaining operational excellence in chemical engineering.
Bookmark this page for streamlined access to Celanese's latest business developments. Stay informed about the specialty materials sector through comprehensive coverage of CE's strategic positioning and industry impact.
Celanese Corporation (NYSE: CE) announced a price increase for several products effective December 1, 2022, or as contracts allow. Notable increases include a 15% hike for UHMW-PE across APAC, AMER, and EMEA, and specific increases per kg for different materials such as 0.50 for LCP and 1.50 for AEM. The company's strong positioning in specialty materials will support these changes, which aim to mitigate rising costs. This strategic decision is consistent with Celanese's efforts to enhance profitability amidst market challenges.
Celanese Corporation (NYSE: CE) reported third quarter 2022 diluted EPS of $1.76 and adjusted EPS of $3.94, with net sales of $2.3 billion, reflecting a 7% decline from the prior quarter. The decrease resulted from a price drop of 3% and a volume reduction of 2%. Operating profit stood at $308 million, impacted by rising costs and a decline in demand, particularly in Europe and Asia. The acquisition of Mobility & Materials completed on November 1, 2022, aims to enhance growth. Fourth quarter adjusted EPS guidance is set between $1.50 and $2.00, factoring in the acquisition's impact.
Celanese Corporation (NYSE: CE) has successfully acquired the majority of the Mobility & Materials (M&M) business from DuPont. This acquisition enables Celanese to enhance its position as a global leader in specialty materials, incorporating renowned brands and extensive product portfolios into its operations. The transaction, initially announced in February 2022, includes a range of engineered thermoplastics and elastomers along with global production capabilities. Future commentary on the acquisition will be provided during the upcoming third-quarter earnings call.
Celanese Corporation (NYSE: CE) has announced the lifting of the force majeure declared on May 11, 2022, for several Acetyl Chain products in the Western Hemisphere, including acetic acid and vinyl acetate monomer. However, the company is unable to lift the force majeure for its acetate tow products due to ongoing supply chain issues. Celanese continues to assess its supply and logistics challenges and will notify when normal supply resumes.
Celanese Corporation (NYSE: CE) has declared a quarterly cash dividend of $0.70 per share, an increase from the previous $0.68 per share, effective November 14, 2022, to shareholders on record as of October 31, 2022. This 3% raise reflects a commitment to returning value to shareholders, representing an additional cash outlay of less than $10 million based on current shares. Celanese emphasizes a decade-long history of annual dividend growth, aligning this increase with their deleveraging plan following the acquisition of Mobility & Materials.
Celanese Corporation (NYSE: CE) has announced a significant investment in expanding its capabilities to meet the rising global demand for pharmaceutical-grade polymers. A new 1,000-square-foot cleanroom facility in Edmonton, Alberta, will be dedicated to cryogenic micronization of VitalDose® EVA material. This process aims to enhance drug delivery solutions for various medical conditions, including cancer and retinal disorders. The facility is expected to begin operations by early 2023, further solidifying Celanese's position in the pharmaceutical market.
Celanese Corporation (NYSE: CE) is set to host its third quarter 2022 earnings call on
Celanese Corporation (NYSE: CE) has received a grant from the Bill & Melinda Gates Foundation to develop a refillable contraceptive implant. This project aims to create a functional prototype within 18 months, focusing on enhancing access to contraceptive options for women in low- and middle-income countries. The development will leverage Celanese's VitalDose® drug delivery technology, which has a strong history in women's health. This initiative aligns with Celanese's mission to expand healthcare access globally.
Celanese Corporation (NYSE: CE) reported second quarter 2022 GAAP diluted EPS of $4.03 and adjusted EPS of $4.99, with net sales of $2.5 billion, reflecting a 2% decrease from the prior quarter but a 13% increase year-over-year. The company successfully offset supply interruptions and inflation, achieving an operating profit of $483 million. Record sales in Engineered Materials reached $948 million. The firm secured $10.5 billion in financing for the DuPont M&M acquisition. However, they anticipate softening demand and expect adjusted EPS of $4.00 to $4.50 for Q3.
